Toripalimab
11 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Phase III RCT of Radiotherapy Plus Toripalimab Versus Sorafenib in Advanced Hepatocellular Carcinoma With PVTT (NCT04709380) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2021-03-02 |
| HAIC Combined With Bevacizumab and Toripalimab for Advanced Hepatocellular Carcinama (NCT04627363) | Sun Yat-sen University | 2021-01-01 |
| Concurrent Chemoradiotherapy With Toripalimab for Local-regional Recurrent Nasopharyngeal Carcinoma: a Prospective, Single-arm, Phase II Trial (NCT04992988) | Cancer Hospital of Guangxi Medical University | 2020-06-28 |
| Toripalimab Combine With Rituximab for Treatment of Relapsed Refractory CD20 Positive Diffuse Large B-cell Lymphoma (NCT04425824) | Chinese Academy of Medical Sciences | 2020-06-15 |
| Anlotinib Plus Toripalimab as First-line Treatment for Advanced Gastric Cancer With ECOG 2 (APICAL-GC) (NCT04278222) | Shanghai Changzheng Hospital | 2020-02-10 |
Track Toripalimab automatically
Every clearance here is in the API, with alerts when new ones post.